Ligand decorated biodegradable nanomedicine in the treatment of cancer.

Ahmad, Ejaj; Ali, Asgar; Fatima, Munazza Tamkeen; Kumar, Arun; Sumi, Mamta P; Sattar, Real Sumayya Abdul; Mahajan, Bhawna; Saluja, Sundeep Singh

Ahmad, Ejaj; Ali, Asgar; Fatima, Munazza Tamkeen; Kumar, Arun; Sumi, Mamta P; Sattar, Real Sumayya Abdul; Mahajan, Bhawna; Saluja, Sundeep Singh.

Afiliação

Ahmad E; Central Molecular Laboratory, Govind Ballabh Pant, Postgraduate Institute of Medica, Education and Research (GIPMER), New Delhi 110002, India.
Ali A; Department of Biochemistry, All India Institute of Medical Science, Patna 810507, India.
Fatima MT; Department of Pharmaceutical Science, College of Pharmacy, QU health, Qatar University, P.O. Box 2713, Doha, Qatar.
Nimisha; Central Molecular Laboratory, Govind Ballabh Pant, Postgraduate Institute of Medica, Education and Research (GIPMER), New Delhi 110002, India.
Apurva; Central Molecular Laboratory, Govind Ballabh Pant, Postgraduate Institute of Medica, Education and Research (GIPMER), New Delhi 110002, India.
Kumar A; Central Molecular Laboratory, Govind Ballabh Pant, Postgraduate Institute of Medica, Education and Research (GIPMER), New Delhi 110002, India.
Sumi MP; Central Molecular Laboratory, Govind Ballabh Pant, Postgraduate Institute of Medica, Education and Research (GIPMER), New Delhi 110002, India.
Sattar RSA; Central Molecular Laboratory, Govind Ballabh Pant, Postgraduate Institute of Medica, Education and Research (GIPMER), New Delhi 110002, India.
Mahajan B; Department of Biochemistry, Govind Ballabh Pant, Postgraduate Institute of Medical, Education and Research (GIPMER), New Delhi 110002, India.
Saluja SS; Central Molecular Laboratory, Govind Ballabh Pant, Postgraduate Institute of Medica, Education and Research (GIPMER), New Delhi 110002, India; Department of GI Surgery, Govind Ballabh Pant, Postgraduate Institute of Medica, Education and Research (GIPMER), New Delhi 110002, India. Electronic address

Pharmacol Res ; 167: 105544, 2021 05.

Article em En | MEDLINE | ID: mdl-33722711

Assuntos

Antineoplásicos/administração & dosagem; Portadores de Fármacos/química; Sistemas de Liberação de Medicamentos; Nanoestruturas/química; Neoplasias/tratamento farmacológico; Animais; Antineoplásicos/farmacocinética; Antineoplásicos/uso terapêutico; Sistemas de Liberação de Medicamentos/métodos; Humanos; Ligantes; Nanomedicina/métodos

Palavras-chave

5-Fluorouracil (PubMed CID: 3385); Biodegradable nanocarriers; CD44; Cisplatin (PubMed CID: 5702198)); Coumarin-6 (PubMed CID: 100334); Curcumin (PubMed CID: 969516); Docetaxel (PubMed CID:148124); Doxorubicin (PubMed CID: 31703); Gemcitabine (PubMed CID: 60750); Hyaluronic Acid; Paclitaxel (PubMed CID: 36314); Phospholipids; Quercetin (PubMed CID: 5280343); Transferrin; Triptolide (PubMed CID: 107985)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Sistemas de Liberação de Medicamentos / Nanoestruturas / Neoplasias / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google